ARYLAMINEN-ACETYLTRANSFERASE ACTIVITY IN MAN

This publication has 33 references indexed in Scilit:

• Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
  Pharmacogenetics, 1998
• Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours
  Cytogenetic and Genome Research, 1997
• Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes
  Human Molecular Genetics, 1994
• A population and family study N-acetyltransferase using caffeine urinary metabolites
  Clinical Pharmacology & Therapeutics, 1993
• Structural Heterogeneity of Caucasian N-Acetyltransferase at the NAT1 Gene Locus
  Archives of Biochemistry and Biophysics, 1993
• SHORT COMMUNICATION: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans
  Carcinogenesis: Integrative Cancer Research, 1993
• Diverse point mutations in the human gene for polymorphic N-acetyltransferase.
  Proceedings of the National Academy of Sciences, 1991
• Human ArylamineN-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional Expression
  DNA and Cell Biology, 1990
• Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylation
  Nucleic Acids Research, 1989
• A simple test for acetylator phenotype using caffeine.
  British Journal of Clinical Pharmacology, 1984